Fund Stats
-
NAV
$38.17
$0.11 (0.29%)
-
Daily YTD Return
6.17%
-
Total Net Assets
$1.8 Billion
-
Inception Date
9/4/90
Overview
The fund invests in the equities of US companies with a range of market capitalizations that we believe offer the best potential for growth.
Key Features
- Seeks to provide attractive returns through an emphasis on higher-growth US companies spanning the full range of market capitalizations and sectors. Draws on more than three decades of experience in growth investing.
- The portfolio reflects top-down, secular thematic views along with high-conviction, fundamentally researched stocks of companies with advantaged business models, high returns on capital, solid free-cash-flow generation, and stewardship-minded management.
- Combines secular and cyclical growth to help manage the dynamics of the economy.
Portfolio Fit
This actively-managed fund seeks to provide attractive returns through its emphasis on higher growth companies primarily in large and mid cap arenas.
Compare Fund
Create real time reports on performance, risk analysis, peer group analysis, style attribution and more on the Investment Professional site.
ComparePerformance
Calendar Year Total Returns
| Date | Calamos Growth Fund (NAV) | Calamos Growth Fund Load-Adjusted | S&P 1500 Growth Index | S&P 500 Index |
|---|---|---|---|---|
| 2021 | 23.27 | 17.4 | 31.16 | 28.71 |
| 2020 | 32.92 | 26.62 | 32.43 | 18.4 |
| 2019 | 31.11 | 24.89 | 30.56 | 31.49 |
| 2018 | -5.87 | -10.34 | -0.82 | -4.38 |
| 2017 | 26.59 | 20.56 | 26.49 | 21.83 |
| 2016 | -2.13 | -6.79 | 7.9 | 11.96 |
| 2015 | 3.02 | -1.86 | 5.21 | 1.38 |
| 2014 | 8.44 | 3.29 | 13.94 | 13.69 |
| 2013 | 33.14 | 26.81 | 33.1 | 32.39 |
| 2012 | 9.33 | 4.15 | 14.81 | 16 |
Annualized Total Returns
| TimeFrame | Calamos Growth Fund (NAV) | Calamos Growth Fund Load-Adjusted | S&P 1500 Growth Index | S&P 500 Index |
|---|---|---|---|---|
| 1 Year | 23.27 | 17.4 | 31.16 | 28.71 |
| 3 Year | 29.03 | 26.96 | 31.38 | 26.07 |
| 5 Year | 20.68 | 19.51 | 23.26 | 18.47 |
| 10 Year | 15.08 | 14.52 | 18.85 | 16.55 |
| Since Inception | 13.72 | 13.55 | 0 | 11.24 |
| TimeFrame | Calamos Growth Fund (NAV) | Calamos Growth Fund Load-Adjusted | S&P 1500 Growth Index | S&P 500 Index |
|---|---|---|---|---|
| 1 Year | 23.27 | 17.4 | 31.16 | 28.71 |
| 3 Year | 29.03 | 26.96 | 31.38 | 26.07 |
| 5 Year | 20.68 | 19.51 | 23.26 | 18.47 |
| 10 Year | 15.08 | 14.52 | 18.85 | 16.55 |
| Since Inception | 13.72 | 13.55 | 11.25 | 11.24 |
Important Fund Information
10k Performance is for the Fund's Class A shares at net asset value and does not include the Fund's maximum front-end sales charge of 4.75%. Had it been included, the Fund's return would have been lower. Results are before taxes on fund distributions and assume reinvestment of dividends and capital gains. Index data shown is from 9/30/90, since comparative index data is available only for full monthly periods. Source: Calamos Investments
Performance data quoted represents past performance, which is no guarantee of future results. Current performance may be lower or higher than the performance quoted. Please refer to Important Risk Information. The principal value and return of an investment will fluctuate so that your shares, when redeemed, may be worth more or less than their original cost. Performance reflected at NAV does not include the Fund's maximum front-end sales load of 4.75%. Had it been included, the Fund's return would have been lower.
The S&P 1500 Growth Index consists of the growth segment of the securities found in the S&P 1500 Index. The S&P 1500 combines the S&P 500, S&P MidCap 400 and the S&P SmallCap 600.
S&P 500 Index is generally considered representative of the US stock market.
Unmanaged index returns, unlike fund returns, do not reflect fees, expenses or sales charges. Investors cannot invest directly in an index.
Average annual total return measures net investment income and capital gain or loss from portfolio investments as an annualized average. All performance shown assumes reinvestment of dividends and capital gains distributions.
The funds' gross expense ratios as of the prospectus dated 3/1/2021 are as follows: A Shares 1.35%, C Shares 2.11% and I Shares 1.10%.
Portfolio
Sector Weightings
| Sector | % of Assets | S&P 1500 Growth Index |
|---|---|---|
| Information Technology | 39.0% | 42.1% |
| Consumer Discretionary | 18.3% | 16.7% |
| Communication Services | 14.0% | 12.2% |
| Health Care | 10.7% | 10.9% |
| Industrials | 9.1% | 4.3% |
| Financials | 4.7% | 7.0% |
| Consumer Staples | 1.8% | 1.5% |
| Materials | 1.5% | 1.6% |
| Energy | 0.4% | 0.8% |
| Real Estate | 0.0% | 2.6% |
| Utilities | 0.0% | 0.1% |
| Other | 0.0% | 0.0% |
Asset Allocation
| Asset Allocation | % |
|---|---|
| Common Stock | 99.3434 |
| Cash and Receivables/Payables | 0.5809 |
| Options | 0.0757 |
Top 10 Holdings
| Company | Security Type | Industry | % |
|---|---|---|---|
| Microsoft Corp. | Stocks | Systems Software | 10.9% |
| Apple, Inc. | Stocks | Technology Hardware, Storage & Peripherals | 7.6% |
| Amazon.com, Inc. | Stocks | Internet & Direct Marketing Retail | 6.8% |
| Alphabet, Inc. - Class A | Stocks | Interactive Media & Services | 6.5% |
| Meta Platforms, Inc. - Class A | Stocks | Interactive Media & Services | 4.9% |
| NVIDIA Corp. | Stocks | Semiconductors | 4.4% |
| Tesla, Inc. | Stocks | Automobile Manufacturers | 4.2% |
| Salesforce.com, Inc. | Stocks | Application Software | 2.3% |
| UnitedHealth Group, Inc. | Stocks | Managed Health Care | 1.8% |
| Thermo Fisher Scientific, Inc. | Stocks | Life Sciences Tools & Services | 1.5% |
| Total | 50.9% |
Fund Facts
| Name | Fund | S&P 1500 Growth Index |
|---|---|---|
| Number of Holdings | 166 | 802 |
| Debt/Capital | 36.2% | 43.7% |
| PEG Ratio | 2.2x | 2.3x |
| Portfolio Turnover (12 months) | 42.5% | N/A |
| Price/Book | 8.6x | 9.8x |
| Price/Earnings | 33.4x | 29.3x |
| Price/Sales | 5.7x | 5.1x |
| ROIC | 28.8% | 31.3% |
| Net Assets | $1.8 B | N/A |
Market Capitalization
| Market CAP Range | % of Assets |
|---|---|
| <=$0.10bil | 0.0% |
| >$0.10bil<=$5bil | 3.5% |
| >$5bil<=$30bil | 11.3% |
| >$30bil<=$200bil | 24.5% |
| >$200bil | 60.7% |
Top Currency Exposures
| Currency | % |
|---|---|
| United States Dollar (USD) | 100.0% |
Distributions
Total Capital Gains
| Year | Capital Gains |
|---|---|
| 2008 | 0.0000 |
| 2009 | 0.0000 |
| 2010 | 0.0000 |
| 2011 | 2.1501 |
| 2012 | 3.7276 |
| 2013 | 15.2925 |
| 2014 | 10.1314 |
| 2015 | 10.9405 |
| 2016 | 1.2028 |
| 2017 | 4.4658 |
| 2018 | 4.3981 |
| 2019 | 3.0256 |
| 2020 | 4.1871 |
| 2021 | 4.9490 |
Schedule
| Name | Frequency |
|---|---|
| Distributions | ANNUAL |
| Capital Gains | ANNUAL |
2021 Capital Gains
Capital gains for Calamos Mutual Funds were declared on December 20, 2021. To view the report, click here.
Distributions
| Frequency | Income | Reinvest |
|---|---|---|
| Q4 2021 | $0.0000 | 38.80000 |
| Q4 2020 | $0.0000 | 0.00000 |
| Q4 2019 | $0.0000 | 30.84000 |
| Q3 2019 | $0.0000 | 0.00000 |
| Q2 2019 | $0.0000 | 0.00000 |
| Q4 2018 | $0.0000 | 25.59000 |
| Q4 2017 | $0.0000 | 32.34000 |
| Q4 2016 | $0.0000 | 29.58000 |
| Q4 2015 | $0.0000 | 30.96000 |
| Q4 2014 | $0.0000 | 40.74000 |
| Q1 2014 | $0.0000 | 0.00000 |
| Q4 2013 | $0.0000 | 45.87000 |
| Q3 2013 | $0.0000 | 0.00000 |
| Q2 2013 | $0.0000 | 0.00000 |
| Q1 2013 | $0.0000 | 0.00000 |
| Q4 2012 | $0.0000 | 47.65000 |
| Q3 2012 | $0.0000 | 0.00000 |
| Q2 2012 | $0.0000 | 0.00000 |
| Q1 2012 | $0.0000 | 0.00000 |
| Q4 2011 | $0.0000 | 46.40000 |
| Q3 2011 | $0.0000 | 0.00000 |
| Q2 2011 | $0.0000 | 0.00000 |
| Q1 2011 | $0.0000 | 0.00000 |
| Q4 2010 | $0.0000 | 0.00000 |
| Q3 2010 | $0.0000 | 0.00000 |
| Q2 2010 | $0.0000 | 0.00000 |
| Q1 2010 | $0.0000 | 0.00000 |
| Q4 2009 | $0.0000 | 0.00000 |
| Q3 2009 | $0.0000 | 0.00000 |
| Q2 2009 | $0.0000 | 0.00000 |
| Q1 2009 | $0.0000 | 0.00000 |
| Q4 2008 | $0.0000 | 0.00000 |
| Q3 2008 | $0.0000 | 0.00000 |
| Q2 2008 | $0.0000 | 0.00000 |
| Q1 2008 | $0.0000 | 0.00000 |
Fees & Expenses
Annual Expenses
| Name | A Shares | C Shares | I Shares |
|---|---|---|---|
| Gross Expense Ratio | 1.35% | 2.11% | 1.10% |
| Net Expense Ratio | 1.35% | 2.11% | 1.10% |
Investment Information
| Name | A Shares | C Shares | I Shares |
|---|---|---|---|
| Minimum initial investment | $2500 | $2500 | $1 million |
| Minimum subsequent investments | $50 | $50 | $0 |
| IRA initial investments | $500 | $500 | N/A |
Fund Information
| Name | A Shares | C Shares | I Shares |
|---|---|---|---|
| Inception Date | 9/04/90 | 9/03/96 | 9/18/97 |
| Ticker Symbol | CVGRX | CVGCX | CGRIX |
| CUSIP number | 128119302 | 128119856 | 128119807 |
Sales & Distribution
| Name | A Shares | C Shares | I Shares |
|---|---|---|---|
| Sales Load | Front-End | Level-Load | N/A |
| Maximum Sales Charge | 4.75 | 1.00 | N/A |
| US Bank Fund Number | 606 | 620 | 630 |
| Dividends | ANNUAL | ANNUAL | ANNUAL |
| Capital Gains | ANNUAL | ANNUAL | ANNUAL |
Literature
Latest Related Blog Posts
About the Fund
Calamos Growth Fund Quarterly Commentary
A quarterly update of the Calamos Growth Fund’s performance, positioning, related market commentary and outlook.
Calamos Growth Fund Fact Sheet
The Growth Fund fact sheet provides a snap shot of the investment team, the fund strategy, performance, composition, ratings and returns.
Prospectus and Reports
Calamos Growth Fund Prospectus
This summary contains important information about the Class A, C, and I Growth Fund investment objective, fees and expenses, principal investment strategies, principal risks and performance.
Statutory Prospectus
You should read the accompanying prospectus and any accompanying prospectus supplement, which contain important information, before deciding whether to invest in our securities.
SAI
The statement of additional information is a supplementary document to the fund’s prospectus and contains additional information about the fund and includes further disclosure regarding its operations.
Semi-Annual Report
The semi-annual report includes a letter from John P. Calamos, Sr. to shareholders and provides a comprehensive review of the fund’s activities and financial performance over a six month period.
Annual Report
The annual report includes a letter from John P. Calamos, Sr. to shareholders outlining the fund's performance, as well as a comprehensive review of the fund’s activities and financial performance.